Human serum albumin (HSA) is an opulent, non-glycosylated, most versatile carrier protein
in plasma possessing multiple functions. HSA has the ability to interact with a variety of …

Glycation involves the non-enzymatic addition of reducing sugars and/or their reactive
degradation products to amine groups on proteins. This process is promoted by the …

Protein glycation provides a biomarker in widespread clinical use, glycated hemoglobin HbA
1c (A1C). It is a biomarker for diagnosis of diabetes and prediabetes and of medium-term …

The presence of excess glucose in blood is regarded as a sweet hurt for patients with
diabetes. Human serum albumin (HSA) is the most abundant protein in human plasma …

Abstract The Human Plasma Proteome has always been the most investigated compartment
in proteomics‐based biomarker discovery, and is considered the largest and deepest …

Glucose reacts with proteins nonenzymatically under physiological conditions. Such
glycation is exacerbated in diabetic patients with high levels of blood sugar and induces …

Diabetes mellitus is the ninth leading cause of mortality worldwide. It is a complex disease
that manifests as chronic hyperglycemia. Glucose exposure causes biochemical changes at …

Human serum albumin (HSA), an abundant protein in human plasma, which is associated
with the transportation of numerous drugs, fatty acids to their targets and regulates the blood …

Protein glycation in biological systems occurs predominantly on lysine, arginine and N-
terminal residues of proteins. Major quantitative glycation adducts are found at mean extents …

This review is the sixth update of the original article published in 1999 on the application of
MALDI mass spectrometry to the analysis of carbohydrates and glycoconjugates and brings …